Skip to content

APOTHEEK PLATEVOET: what changed

What changed

APOTHEEK PLATEVOET

BE 0446.787.740
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Financial years compared with
Net result for the year
-€18,218
2025 · -€5,952-€12,266
Equity
€1.3m
2025 · €1.3m-€18,218
Cash
€66,905
2025 · €39,019+€27,886
Balance sheet total
€1.3m
2025 · €1.4m-€86,182

Largest movements

2025 to 2026
Assets
  • Receivables after one year -€48,979

    down €48,979 (-4.5%), from €1.1m to €1.0m

  • Stocks and contracts -€34,088

    down €34,088 (-41.9%), from €81,342 to €47,253

  • Receivables within one year -€30,005

    down €30,005 (-40.5%), from €74,067 to €44,061

    of which Trade receivables: -€30,034

  • Cash +€27,886

    up €27,886 (+71.5%), from €39,019 to €66,905

    mainly Receivables after one year (+€48,979) and Stocks and contracts (+€34,088)

Equity and liabilities
  • Short-term financial debts -€50,000

    down €50,000 (-100%), from €50,000 to €0

  • Reserves -€18,218

    down €18,218 (-1.4%), from €1.3m to €1.3m

    of which Distributable reserves: -€18,218

Income statement
  • Gross operating margin -€35,199

    down €35,199 (-38.1%), from €92,285 to €57,085

  • Staff costs -€18,934

    down €18,934 (-21.5%), from €88,210 to €69,276

  • Financial charges -€4,801

    down €4,801 (-47.4%), from €10,134 to €5,333

  • Financial income -€2,600

    down €2,600 (-75.3%), from €3,451 to €851

  • Other operating charges -€1,798

    down €1,798 (-53.8%), from €3,343 to €1,545

Change in the result, 2025 to 2026

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2025 -€5,952
Gross operating margin -€35,199
Staff costs +€18,934
Other operating charges +€1,798
Financial income -€2,600
Financial charges +€4,801
Result 2026 -€18,218
raises the resultlowers the result

Derived cash bridge

cash 2025 to 2026

The bridge is derived from the 2025 and 2026 balance sheets and the 2026 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€77,894
Investment €0
Financing -€50,008
Cash 2025 €39,019
Net result for the year -€18,218
Receivables after one year +€48,979
Stocks and contracts +€34,088
Receivables within one year +€30,005
Deferred charges and accrued income +€996
Trade debts -€13,796
Tax, wage and social debts -€4,160
Current portion of long-term debt -€8
Short-term financial debts -€50,000
Cash 2026 €66,905
brings cash intakes cash out
Every line side by side 43 lines
Line Code 2025 2026 Change %
Total assets 20/58 €1,404,648 €1,318,466 -€86,182 -6.1%
Fixed assets 21/28 €86,048 €86,048 = 0.0%
Financial fixed assets 28 €86,048 €86,048 = 0.0%
Current assets 29/58 €1,318,600 €1,232,418 -€86,182 -6.5%
Amounts receivable after more than one year 29 €1,097,791 €1,048,812 -€48,979 -4.5%
Other amounts receivable 291 €1,097,791 €1,048,812 -€48,979 -4.5%
Stocks and contracts in progress 3 €81,342 €47,253 -€34,088 -41.9%
Stocks 30/36 €81,342 €47,253 -€34,088 -41.9%
Amounts receivable within one year 40/41 €74,067 €44,061 -€30,005 -40.5%
Trade receivables 40 €64,635 €34,600 -€30,034 -46.5%
Other amounts receivable 41 €9,432 €9,461 +€29 +0.3%
Cash at bank and in hand 54/58 €39,019 €66,905 +€27,886 +71.5%
Deferred charges and accrued income 490/1 €26,382 €25,386 -€996 -3.8%
Total equity and liabilities 10/49 €1,404,648 €1,318,466 -€86,182 -6.1%
Equity 10/15 €1,284,375 €1,266,157 -€18,218 -1.4%
Contributions 10/11 €6,200 €6,200 = 0.0%
Reserves 13 €1,278,175 €1,259,957 -€18,218 -1.4%
Non-distributable reserves 130/1 €2,479 €2,479 = 0.0%
Reserves not available under the articles 1311 €2,479 €2,479 = 0.0%
Distributable reserves 133 €1,275,696 €1,257,478 -€18,218 -1.4%
Amounts payable 17/49 €120,273 €52,309 -€67,964 -56.5%
Amounts payable within one year 42/48 €120,273 €52,309 -€67,964 -56.5%
Current portion of amounts payable after more than one year 42 €1,937 €1,929 -€8 -0.4%
Financial debts 43 €50,000 €0 -€50,000 -100%
Credit institutions 430/8 €50,000 €0 -€50,000 -100%
Trade debts 44 €50,572 €36,776 -€13,796 -27.3%
Suppliers 440/4 €50,572 €36,776 -€13,796 -27.3%
Taxes, remuneration and social security 45 €17,765 €13,604 -€4,160 -23.4%
Taxes 450/3 €503 €238 -€265 -52.6%
Remuneration and social security 454/9 €17,262 €13,366 -€3,896 -22.6%
Remuneration, social security and pensions 62 €88,210 €69,276 -€18,934 -21.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €0 - =
Other operating charges 640/8 €3,343 €1,545 -€1,798 -53.8%
Gross operating margin 9900 €92,285 €57,085 -€35,199 -38.1%
Operating profit (loss) 9901 €731 -€13,736 -€14,467
Financial income 75/76B €3,451 €851 -€2,600 -75.3%
Recurring financial income 75 €3,451 €851 -€2,600 -75.3%
Financial charges 65/66B €10,134 €5,333 -€4,801 -47.4%
Recurring financial charges 65 €10,134 €5,333 -€4,801 -47.4%
Profit (loss) for the period before taxes 9903 -€5,952 -€18,218 -€12,266 -206%
Income taxes 67/77 €0 - =
Profit (loss) for the period 9904 -€5,952 -€18,218 -€12,266 -206%
Profit (loss) for the period to be appropriated 9905 -€5,952 -€18,218 -€12,266 -206%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 28 February 2025 and 28 February 2026. Green is a favourable move for that line, red an unfavourable one. Prepared on 4 November 2026 via checked.be.